• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY V3.7
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Convulsion/Seizure (4406)
Event Date 10/24/2023
Event Type  Injury  
Manufacturer Narrative
Provider contacted neuronetics to report that one of their patients experienced a non-epileptic seizure around 8:30-9:00 pm.The patient had received her 18th tms treatment session earlier that same day around 3:00 pm.The patient reportedly was sleeping and got up to go to the bathroom which is when the event occurred.The patient's husband called 911 and the patient was taken to the er and was subsequently admitted to the hospital for 5 days.Patient had an eeg and mri which were found to be normal.The patient also met with a neurologist while in the hospital though patient reported that they did not "find out a reason" for the event.The patient was on lamictal previously for her mdd but in response to the event, her dose was increased.The patient is on several medications that could potentially lower the seizure threshold and has had a similar episode of non-epileptic seizure in the past.Per the provider, the patient has not been taking her medications as prescribed.These factors could have contributed to the event.
 
Event Description
Provider contacted neuronetics to report that one of their patients experienced a seizure in the middle of the night and was subsequently hospitalized.Patient had received their 18th tms treatment session earlier the same day the event occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
anna gorbunov
3222 phoenixville pike
malvern, PA 19355
6106404202
MDR Report Key18187409
MDR Text Key328742760
Report Number3004824012-2023-00026
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00850005944522
UDI-Public00850005944522
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K230029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberNEUROSTAR ADVANCED THERAPY V3.7
Device Catalogue Number81-04335-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/30/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
BUSPAR 15 MG THREE TIMES A DAY; LAMICTAL 200 MG DAILY; PRISTIQ 100 MG DAILY; REMERON 15 MG AT BEDTIME; TRAZODONE 50 MG AT BEDTIME
Patient Outcome(s) Other;
Patient Age57 YR
Patient SexFemale
Patient RaceWhite
-
-